1. #1
    Hiatus Board Certified Psy.D

    Join Date
    Oct 2016
    Posts
    449
    Rep Power
    0

    Default Toremifene (Fareston) Facts/Profile


    Overview and History of Toremifene

    Toremifene is a member of a category, family, and class of drugs that are known as SERMs (Selective Estrogen Receptor Modulators). SERMs fall under an even broader category of drugs that are known as anti-estrogens, and the cousin family of SERMs (that also fall under anti-estrogens) are aromatase inhibitors, commonly abbreviated as AIs. SERMs include compounds such as Toremifene, Nolvadex (Tamoxifen), and Clomid (Clomiphene Citrate). Aromatase inhibitors (AIs) include compounds such as Arimidex (Anastrozole), Aromasin (Exemestane), and Letrozole (Femara). Although the two fall under the category of anti-estrogens, they are both sub-categories that branch off into their own families, as SERMs and AIs differ greatly in their mechanism of action within the human body concerning how they control or block Estrogen. There has been much misunderstanding and misconception in previous decades as to what each of these do, and this should always be first clarified to the reader before describing Toremifene.

    SERMs are true ‘Estrogen blockers’, while AIs are not. SERMs act to block the activity of Estrogen at their target receptor sites in different tissues (mainly breast tissue), and they do this by binding more strongly to the Estrogen receptors in these tissues than Estrogen itself, effectively taking the spot that Estrogen normally would. The SERMs will remain bound to the receptor site and remain inert (they will not activate the receptors or perform any actions) This results in the inability for Estrogen to bind to these receptors (as they are already occupied by the SERM). While SERMs block Estrogenic activity at certain receptor sites, SERMs can and do also act as estrogens themselves in other receptor sites in other tissues in the body (such as in the liver, which can be beneficial). This is known as Estrogen agonist and Estrogen antagonist activity. In any case, SERMs do not serve to lower overall total circulating blood plasma levels of Estrogen in the body – they merely block its activity in certain tissues. Aromatase inhibitors (AIs) are instead the compounds that will reduce total circulating levels of Estrogen in the body by way of binding to the enzyme responsible for the conversion (aromatization) of androgens into Estrogen. This enzyme is known as aromatase. AIs are more attractive as a substrate to the aromatase enzyme than the aromatase enzyme’s traditional substrate targets, which are androgens (such as Testosterone). The result is that the aromatase enzyme is occupied with the AI, and therefore cannot engage in chemical reactions with androgens. This results in the inability for Estrogen to be manufactured at its root source, and therefore Estrogen levels as a whole are reduced in the body.

    As far as Toremifene is concerned, it is a SERM with mixed agonist and antagonist properties on the Estrogen receptor, and is classified as a triphenylethylene analogue that is very similar in structure to Nolvadex (Tamoxifen) and Clomid (Clomiphene Citrate). Toremifene (Fareston) could be considered a very close sister to Nolvadex, as they are very similar. Toremifene is also a non-steroidal compound. It is classified as a breast cancer drug in the treatment of female post-menopausal breast cancer that is determined to be Estrogen-receptor positive (or Estrogen-receptor unknown). What this means is that it is a drug that is utilized for the purpose of blocking and treating female breast cancer that is exacerbated by Estrogen via Estrogen’s activity at breast tissue receptors, which can promote cancerous growth through its tissue growth promoting activity within breast tissue. Toremifene, as previously described, binds to these receptor sites and blocks the ability for Estrogen itself to continue activating receptor sites within breast tissue, thus blocking or halting the progress of tumor growth that could be exacerbated by Estrogen.

    Toremifene has gained popularity with anabolic steroid using bodybuilders and athletes for the exact same reasons that Nolvadex has: it is used to counter act and/or block some of the effects of excessive Estrogen in the body as a result of aromatization of various androgens used (such as Testosterone or Dianabol, for example). In particular, Toremifene is used to mitigate, alleviate, and/or prevent the Estrogen-related side effect of gynecomastia (the development of breast tissue on males).

    fareston1Toremifene Citrate is a very new and recent compound that was approved by the FDA in 1997 as a prescription drug, and is sold most popularly under the brand and trade name Fareston on the US prescription market. GTx, Inc. was the first and current pharmaceutical company to undertake the manufacture of Toremifene under the brand name Fareston. Toremifene under the brand name of Fareston is also available in a plethora of other countries internationally as well, such as: Turkey, Thailand, Africa, Switzerland, Spain, Portugal, Russia, Sweden, Germany, Greece, Finland, Ireland, Hungary, France, South Africa, Australia, Czech Republic, Australia, Italy, and England (the United Kingdom). It is a very popular and widespread product, much like its close relative Nolvadex and can be found almost anywhere throughout the world.

    The question that remains (and that is commonly asked) concerning Toremifene is whether or not it is just as effective, more effective, and/or more advantageous than its older sister Nolvadex. These questions will soon be answered here as well as in the later sections of this profile.

    Chemical Characteristics of Toremifene

    Toremifene (Fareston) is a non-steroidal selective Estrogen receptor modulator (SERM) that expresses both mixed agonistic as well as antagonistic properties in relation to Estrogen in different tissues and cells within the human body. Toremifene is a member of a family of compounds known as triphenylethylene compounds, which Nolvadex (Tamoxifen) as well as Clomid (Clomiphene Citrate) are both also members of, and are both in particular very closely related compounds to each other.

    Properties of Toremifene

    It has already been covered that Toremifene is a SERM, and serves to block Estrogen at various receptor sites in certain tissues within the body (breast tissue in particular). As a layman explanation, Toremifene pretends to be a ‘fake’ Estrogen that occupies Estrogen receptors within breast tissue. With these receptors occupied by Toremifene, real Estrogen cannot perform their jobs there. Toremifene does not reduce total blood plasma levels of Estrogen. In addition to being antagonistic to Estrogen receptors in breast tissue, it is also antagonistic to Estrogen at the hypothalamus gland (this essentially ‘tricks’ the hypothalamus into thinking there is little or no circulating Estrogen levels in the body, causing it to increase its manufacture of Testosterone so that it can utilize aromatization to restore these levels. Toremifene is also agonistic to Estrogen receptors in other tissues in the body (within the liver in particular). This means that while Toremifene will act as an anti-estrogen in breast tissue and the hypothalamus, it will act as an Estrogen within the liver. This can have beneficial impacts especially during an anabolic steroid cycle, such as improving and shifting cholesterol levels into a more favorable range.

    Although Toremifene is closely related to Nolvadex, it does differ quite a bit in other aspects that have been discovered (some good and some bad). In comparison with Nolvadex, the first issue to observe is the growing concern many have towards the carcinogenic effects on liver tissue that Nolvadex exhibits. It should be understood that these effects have been observed with extremely long term use and that it should not be a problem with the very short term use that bodybuilders and athletes are engaged in, but it should be comforting for some to know that Toremifene less liver toxic/carcinogenic effects than Nolvadex, but individuals should still be aware that because Toremifene is still an analogue of Nolvadex, it does still exhibit many of the related toxic effects on the liver.

    There is also clinical evidence that Toremifene may express an advantage over other SERMs such as Nolvadex through an ability to not only exhibit inhibition of breast tissue growth, but also apoptosis (or programmed cell death) of breast tissue and tumor cells in breast cancer patients. This is very promising evidence and information, but it should be understood that often times breast cancer patients will react very differently from healthy individuals to different drug treatments. But this should provide some evidence that Toremifene could very well destroy gynecomastia tissue in addition to halting and preventing its growth. Toremifene (Fareston) has also demonstrated the capability to reduce Prolactin levels in the body at 300mg per day after 8 weeks. This is very pleasing information, as Toremifene could possibly be utilized as an anti-Prolactin drug if needed. It is possible, however, that this might only occur in breast cancer patients.

    There are some negative aspects and properties to Toremifene, however. Firstly and perhaps most importantly is the negative effect that Tore exhibits on SHBG (Sex Hormone Binding Globulin) levels in the body, where clinical research has demonstrated that while Toremifene can and does stimulate natural endogenous production of Testosterone (which is a good thing for post-cycle therapy – PCT), it in fact raises SHBG levels in the body. What this means for the bodybuilder, athlete, and anabolic steroid user is that raises in SHBG will mean less free Testosterone will be present in the body. SHBG is a protein that binds to sex hormones such as Testosterone and renders it inactive while it is bound to it, in effect ‘handcuffing’ Testosterone (or other androgens and sex hormones that are susceptible to SHBG). The result is the hormone it binds to (in this case, Testosterone) ends up merely floating around in circulation unable to do its job (free vs. bound Testosterone). Elevations in SHBG are therefore not a very good thing for post-cycle recovery or for performance enhancement during cycle, which may detract from Toremifene’s potential as a recovery compound during PCT (Post Cycle Therapy). In comparison, Nolvadex has not been proven to have this effect on SHBG during the over five decades of its use and study (compared to Toremifene’s less than one and a half decade of study and use).

    Furthermore, in the department of restoring HPTA (Hypothalamic Pituitary Testicular Axis) function during PCT, Toremifene has demonstrated itself to be less efficient than Nolvadex for this purpose. In this study, 20mg per day of Tamoxifen (Nolvadex) over a period of 8 weeks increased LH (Luteinizing Hormone) levels upwards of 70%, resulting in an increase in Testosterone levels of 71%. In comparison, Toremifene administered over the same amount of time at 60mg per day resulted in only a 25% increase in LH levels and a 42% increase in Testosterone levels. It should be important to note, however, that 60mg per day of Toremifene is regarded as a lower dose for this purpose, but this should still clearly highlight the fact that Nolvadex remains the most potent and effective SERM among all three SERMs for this purpose, requiring the lowest dose out of all of them in order to elicit a positive effect on HPTA function. More information on suitable doses will be discussed in the Toremifene Dosage section of this profile.



    Toremifene Citrate (AKA Fareston, Acapodene)
    Chemical Name: 2-{4-[(1Z)-4-chloro-1,2-diphenyl-but-1-en-1-yl]phenoxy}-N,N-dimethylethanamine
    Molecular Weight: 405.959 g/mol
    Formula: C26H28ClNO
    Original Manufacturer: GTx, Inc.
    Half Life: 5 days
    Detection Time: Unknown
    Anabolic Rating: N/A
    Androgenic Rating: N/A


    Sent from my iPhone using Tapatalk
    Thanks thudgens96 thanked for this post
    Likes thudgens96 liked this post
     

  2. #2
    SPONSORS Board Certified Psy.D
    Macedog24's Avatar
    Join Date
    Jan 2016
    Posts
    157
    Rep Power
    2147483813

    Default

    Toremifene is my favorite serm . what it does for your manhood and how you feel. Incredible. Your boys come back in 2-3 days. Also, you can run letro along side it. Nolva on the other hand you shouldnt. There is a reduction in its effectiveness by 40%

    Sent from my LG-LS997 using Tapatalk
    Likes GotTren, thudgens96 liked this post
     

  3. #3
    Hiatus Board Certified Psy.D

    Join Date
    Oct 2016
    Posts
    449
    Rep Power
    0

    Default

    Quote Originally Posted by Macedog24 View Post
    Toremifene is my favorite serm . what it does for your manhood and how you feel. Incredible. Your boys come back in 2-3 days. Also, you can run letro along side it. Nolva on the other hand you shouldnt. There is a reduction in its effectiveness by 40%

    Sent from my LG-LS997 using Tapatalk
    Toremifene is one of those underrated drugs that suppresses estrogen. One thing is that it is tough to find and not many UGLs carry it. Once it gains some more popularity hopefully the selection will open up a bit.


    Sent from my iPhone using Tapatalk
    Likes thudgens96 liked this post
     

  4. #4
    Hiatus Board Certified Psy.D

    Join Date
    Oct 2016
    Posts
    449
    Rep Power
    0

    Default



    Fareston Tabletten 60mg


    Sent from my iPhone using Tapatalk
     

  5. #5
    Hiatus Board Certified Psy.D

    Join Date
    Oct 2016
    Posts
    449
    Rep Power
    0

    Default



    APex peptides Toremifene citrate 60mg


    Sent from my iPhone using Tapatalk
     

Similar Threads

  1. Sustanon 250 Facts/Profile
    By GotTren in forum Anabolic Steroid Reviews
    Replies: 14
    Last Post: 08-22-2018, 08:29 AM
  2. Turinabol Facts/ Profile
    By GotTren in forum Anabolic Steroid Reviews
    Replies: 12
    Last Post: 01-20-2017, 11:14 PM
  3. Omnadren 250 Facts/Profile
    By GotTren in forum Anabolic Steroid Reviews
    Replies: 6
    Last Post: 12-25-2016, 05:44 PM
  4. Fareston profile
    By guardianactual in forum MuscleChemistry Discussion
    Replies: 1
    Last Post: 05-07-2014, 05:16 AM
  5. Fareston is a Selective Estrogen Receptor Modulator (SERM). Fareston Dosages
    By gandhisays in forum Bodybuilding Steroid & Training Articles
    Replies: 0
    Last Post: 03-22-2013, 05:36 PM

Tags for this Thread

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •  

Log in